±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 425  |  »Ø¸´: 1

l»ØÒä

гæ (³õÈëÎÄ̳)

[ÇóÖú] ºÜ¼±£¡£¡Çó°ïæ°¡£¬·­ÒëÎÄÏ×ÖеÄһЩ»°£¡£¡

Nevirapine is an anti-human immunodeficiency virus (HIV) agent that belongs to the class of the non-nucleoside inhibitors of the HIV-1 virus reverse transcriptase. Spectral characteristics of nevirapine have been probed into by methods of Fourier transform infrared (FTIR), FT-Raman, UV-visible, and quantum chemistry. The UV spectrum was measured in methanol. In order to gain some valuable insight into the recorded spectrum, the quantum mechanical calculations were performed for nevirapine using both ZINDO and time-dependent density functional theory at B3LYP/6-31G(d,p) level. The optimized molecular geometry, bond orders, natural bond order analysis, and harmonic vibrational wavenumbers of nevirapine were calculated by restricted Hartree-Fock and density functional B3LYP methods with the 6-31G(d,p) basis set using Gaussian 03 W program. The harmonic vibrational frequencies calculated have been compared with experimental FTIR and FT-Raman spectra. The restricted Hartree-Fock and density functional theory-based nuclear magnetic resonance (NMR) calculation procedure was also performed, and it was used for assigning the 13C and 1H NMR chemical shifts of nevirapine.
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

´óÁ³¸ãѧÊõ

Í­³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
l»ØÒä(RXMCDM´ú·¢): ½ð±Ò+10, ¶àлӦÖú£¡ 2015-09-02 23:32:44
Nevirapine£¨Ó¦¸ÃÊÇÒ»ÖÖÒ©ÎÊÇÒ»ÖÖ¿¹ÃâÒßȱÏݲ¡¶¾£¨HIV£©µÄÒ©ÎÊôÓÚÒÖÖÆHIV-1Äæ×ªÂ¼µÄ·ÇºËÜÕÒÖÖÆ¼Á¡£ NevirapineµÄÐÔÖÊÆ×ͼ¿ÉÒÔÓúìÍ⸵Á¢Ò¶,FTÀ­Âü£¬¿É¼û×ÏÍâÏßÒÔ¼°Á¿×Ó»¯Ñ§·½·¨À´Ì½Îö£¨Ó¦¸ÃÊÇרҵÊõÓï°É£©¡£ÆäUVÆ×¿ÉÒÔÓü״¼²âÁ¿¡£ÎªÁ˶ԼǼµÄ¹âÆ×½øÐÐÉîÈëÓÐÒâÒåµÄ·ÖÎö£¬ÎÒÃÇÔÚB3LYP/6-31G(d,p) ¼¶±ðͬʱÓÃZINDOºÍº¬Ê±Ãܶȷºº¯ÀíÂÛÀ´µÃµ½nevirapineµÄÁ¿×Ó»úеËã·¨¡£ÎÒÃÇʹÓÃÏÞÖÆµÄHartree-FockºÍÃܶȷ½³Ì B3LYPµÃµ½nevirapine µÄ×îÓÅ·Ö×Ó¼¸ºÎ¡¢Å¦´ø²ã¼¶£¨²»È·¶¨£©¡¢×ÔȻŦ´ø´Ô¼¯·ÖÎöÒÔ¼°Ð³Õñ¶¯²¨Êý£¬ÆäÖÐ B3LYP·½·¨Ê¹Óà 6-31G(d,p)»ù´¡µã²¢Ê¹Óøß˹03 W³ÌÐò¡£¼ÆËãµÃµ½µÄгÕñ¶«ÆµÂÊÓëʵÑéµÃµ½µÄºìÍâÆ×ºÍÀ­ÂüÆ×¶ÔÕÕ¡£ÎÄÖÐͬʱ¸ø³öÁËÏÞÖÆ Hartree-FockºÍÒÔÃܶȺ¯ÊýÀíÂÛΪ»ù´¡µÄºË´Å¹²ÕñµÄ¼ÆËã¹ý³Ì¡£ÎÄÖÐËùÓ÷½·¨¿ÉÒÔÓÃÀ´Ñо¿nevirapineµÄ13C and 1H NMRµÄ»¯Ñ§Æ«ÒÆ¡£
ºÃ¶àרҵ´Ê»ã£¬ÎÞÄΰ³ÊÇѧÒÇÆ÷µÄ£¬×¨Òµ°³²»¶®£¬ÄãÔÙ¿´×ŸĸİÉ~
2Â¥2015-04-09 14:44:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ l»ØÒä µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085601Ò»Ö¾Ô¸±±Àí325·ÖÇóµ÷¼Á +6 ÕÒµ÷¼Á£¬£¬ 2026-04-02 6/300 2026-04-03 22:20 by –¹Æ?
[¿¼ÑÐ] ¿¼Ñе÷¼Á +5 СsunÒªºÃÔË 2026-04-03 5/250 2026-04-03 21:43 by à£à£à£0119
[¿¼ÑÐ] 332Çóµ÷¼Á +8 @MZB382400 2026-03-28 8/400 2026-04-03 19:31 by lijunpoly
[¿¼ÑÐ] 301Çóµ÷¼Á +15 ÂæÍÕÄÐÈË 2026-04-02 15/750 2026-04-03 18:26 by lsÁõ˧
[¿¼ÑÐ] 285Çóµ÷¼Á +5 AZMK 2026-04-03 8/400 2026-04-03 18:17 by AZMK
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬×Ü·Ö320Çóµ÷¼Á +7 À§À§À§À§À¤À¤ 2026-04-02 7/350 2026-04-03 17:26 by Yuena_Wang
[¿¼ÑÐ] 334Çóµ÷¼Á +9 Trying] 2026-03-31 9/450 2026-04-03 15:18 by ×ÁçíØ¼
[¿¼ÑÐ] 368Çóµ÷¼Á +4 ½ñ»ªÏ° 2026-04-03 6/300 2026-04-03 13:46 by ½ñ»ªÏ°
[¿¼ÑÐ] ±¾¿ÆÐÂÄÜÔ´¿ÆÑ§Ó빤³Ì£¬Ò»Ö¾Ô¸»ªÀíÄܶ¯285Çóµ÷¼Á +9 AZMK 2026-03-28 13/650 2026-04-03 11:18 by qqq850810
[¿¼ÑÐ] 349Çóµ÷¼Á +10 zwjjjjjj 2026-03-31 10/500 2026-04-02 20:13 by dongzh2009
[¿¼ÑÐ] 279Çóµ÷¼Á +5 ¸µÎÄÇï 2026-04-02 5/250 2026-04-02 18:10 by ±ÊÂä½õÖÝ
[¿¼ÑÐ] »·¾³¹¤³Ì297·ÖÇóµ÷¼ÁÒ»Ö¾Ô¸º¼¸ßÔº +15 GENJIOW 2026-03-31 16/800 2026-04-02 17:56 by cyh¡ª315
[¿¼ÑÐ] 26¿¼Ñе÷¼Á +4 Wnz.20030617 2026-04-01 5/250 2026-04-02 16:11 by 1939136013¹·×³
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +3 ´Þwj 2026-04-02 3/150 2026-04-02 15:06 by cal0306
[¿¼ÑÐ] 292·Ö£¬²ÄÁÏÓ뻯¹¤£¬ÉêÇëµ÷¼Á +19 ³ÌÇçÖ® 2026-04-01 23/1150 2026-04-02 11:59 by ³ÌÇçÖ®
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +11 Ò»ÑùYWY 2026-03-31 11/550 2026-04-01 22:25 by zhouyuwinner
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +5 Ë«ÂíβƦÀϰå2 2026-03-31 5/250 2026-04-01 09:04 by oooqiao
[¿¼ÑÐ] ±¾¿Æ211×Ü·Ö289£¬08¹¤Ñ§ÕæÐÄÇóµ÷¼Á +3 utopiaE 2026-03-30 3/150 2026-03-30 23:42 by ms629
[¿¼ÑÐ] 0703»¯Ñ§321·ÖÇóµ÷¼Á +10 Èýdd. 2026-03-30 11/550 2026-03-30 19:24 by markhwc
[¿¼ÑÐ] 296Çóµ÷¼Á +10 ±Ë°¶t 2026-03-29 10/500 2026-03-30 10:50 by ̽123
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û